Molecular Characteristics of IDH2-Mutated, Philadelphia Chromosome-Negative, Advanced-Phase Myeloproliferative Neoplasms Treated with Enasidenib

被引：0
|
作者：
Patel, Anand [1 ]
Cahill, Kirk [1 ]
Charnot-Katsikas, Angella [2 ]
Liu, Hongtao [1 ]
Gurbuxani, Sandeep [2 ]
Thirman, Michael [1 ]
Kosuri, Satyajit [1 ]
Larson, Richard [1 ]
Stock, Wendy [1 ]
Segal, Jeremy [2 ]
Odenike, Olatoyosi [1 ]
机构：
[1] Univ Chicago Med, Hematol Oncol Sect, Dept Med, Chicago, IL USA
[2] Univ Chicago Med, Dept Pathol, Chicago, IL USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
blast-phase MPN; myeloproliferative neoplasms; accelerated-phase MPN; IDH;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MPN-288
引用
收藏
页码：S335 / S336
页数：2
相关论文
共 20 条
  • [1] Impact of Comorbidities in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
    Ahmed, Shima A.
    Aly, Mai M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S336 - S336
  • [2] Somatic Mutations in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
    Cristina, Sergio Ferreira
    Polo, Blanca
    Lacerda, Joao F.
    SEMINARS IN HEMATOLOGY, 2018, 55 (04) : 215 - 222
  • [3] Epidemiology of the Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms
    Shallis, Rory M.
    Zeidan, Amer M.
    Wang, Rong
    Podoltsev, Nikolai A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (02) : 177 - 189
  • [4] Philadelphia chromosome-negative myeloproliferative neoplasms: clinical aspects and treatment options
    Gotoh, Akihiko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (05) : 616 - 618
  • [5] Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms
    Holmstrom, Morten Orebo
    Hasselbalch, Hans Carl
    Andersen, Mads Hald
    CANCERS, 2020, 12 (07) : 1 - 21
  • [6] Philadelphia chromosome-negative myeloproliferative neoplasms: clinical aspects and treatment options
    Akihiko Gotoh
    International Journal of Hematology, 2022, 115 : 616 - 618
  • [7] Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms
    Gianelli, Umberto
    Bossi, Anna
    Cortinovis, Ivan
    Sabattini, Elena
    Tripodo, Claudio
    Boveri, Emanuela
    Moro, Alessia
    Valli, Riccardo
    Ponzoni, Maurilio
    Florena, Ada M.
    Orcioni, Giulio F.
    Ascani, Stefano
    Bonoldi, Emanuela
    Iurlo, Alessandra
    Gugliotta, Luigi
    Franco, Vito
    MODERN PATHOLOGY, 2014, 27 (06) : 814 - 822
  • [8] Associations of Physical and Psychologic Symptom Burden in Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
    McFarland, Daniel C.
    Shaffer, Kelly M.
    Polizzi, Heather
    Mascarenhas, John
    Kremyanskaya, Marina
    Holland, Jimmie
    Hoffman, Ronald
    PSYCHOSOMATICS, 2018, 59 (05) : 472 - 480
  • [9] Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
    Cominal, Jucara Gastaldi
    Cacemiro, Maira da Costa
    Berzoti-Coelho, Maria Gabriela
    Pereira, Illy Enne Gomes
    Frantz, Fabiani Gai
    Souto, Elizabeth Xisto
    Covas, Dimas Tadeu
    Figueiredo-Pontes, Lorena Lobo de
    Oliveira, Maria Carolina
    Malmegrim, Kelen Cristina Ribeiro
    Castro, Fabiola Attie de
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Effect of Charlson comorbidity index on vascular events and survival in Philadelphia chromosome-negative myeloproliferative neoplasms
    Ahmed, Shimaa A.
    Aly, Mai M.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2021, 46 (02) : 111 - 115
12